Amgen, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0311621009
USD
340.16
1.8 (0.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Halozyme Therapeutics, Inc.
Gilead Sciences, Inc.
BioMarin Pharmaceutical, Inc.
Amgen, Inc.
Moderna, Inc.
Biogen, Inc.
Illumina, Inc.
Elanco Animal Health, Inc.
Bio-Techne Corp.
Vaxcyte, Inc.
Immunovant, Inc.
Why is Amgen, Inc. ?
1
High Management Efficiency with a high ROCE of 22.31%
2
Positive results in Jun 25
  • OPERATING CASH FLOW(Y) Highest at USD 12,013 MM
  • DIVIDEND PER SHARE(HY) Highest at USD 4.45
  • PRE-TAX PROFIT(Q) At USD 1,554 MM has Grown at 100.26%
3
With ROCE of 16.26%, it has a fair valuation with a 3.74 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 16.02%, its profits have risen by 79.9% ; the PEG ratio of the company is 0.3
4
High Institutional Holdings at 82.18%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 1.98% over the previous quarter.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Amgen, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Amgen, Inc. for you?

Low Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Amgen, Inc.
22.22%
0.44
27.25%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
7.58%
EBIT Growth (5y)
1.46%
EBIT to Interest (avg)
4.81
Debt to EBITDA (avg)
2.91
Net Debt to Equity (avg)
7.83
Sales to Capital Employed (avg)
0.45
Tax Ratio
10.78%
Dividend Payout Ratio
119.05%
Pledged Shares
0
Institutional Holding
82.18%
ROCE (avg)
22.31%
ROE (avg)
234.10%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
25.15
EV to EBIT
22.97
EV to EBITDA
14.13
EV to Capital Employed
3.74
EV to Sales
6.03
PEG Ratio
0.27
Dividend Yield
3.18%
ROCE (Latest)
16.26%
ROE (Latest)
116.13%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 12,013 MM

DIVIDEND PER SHARE(HY)

Highest at USD 4.45

PRE-TAX PROFIT(Q)

At USD 1,554 MM has Grown at 100.26%

RAW MATERIAL COST(Y)

Fallen by -9.94% (YoY

NET SALES(Q)

Highest at USD 9,167 MM

NET PROFIT(Q)

At USD 1,419.21 MM has Grown at 94.66%

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Here's what is working for Amgen, Inc.
Pre-Tax Profit
At USD 1,554 MM has Grown at 100.26%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Dividend per share
Highest at USD 4.45 and Grown
In each year in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (USD)

Operating Cash Flow
Highest at USD 12,013 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
Highest at USD 9,167 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Profit
At USD 1,419.21 MM has Grown at 94.66%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Raw Material Cost
Fallen by -9.94% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales